Vivacelle Bio, Inc. Announces FDA Clearance to Enroll Patients into a Phase IIa Clinical Trial of VBI-S for Elevation of Blood Pressure in Subjects Who Have Shock Due to Sepsis


CHICAGO–(BUSINESS WIRE)–Vivacelle Bio received FDA clearance to proceed with its trial of VBI-S, a groundbreaking therapy for shock due to sepsis….